Made In India syrups caused 300 deaths globally

▴ INDIAN COUGH SYRUP DEATH GAMBIA
WHO (World Health Organization) made an alert on the manufacture of Made-in-India medicines such as cough syrups and vitamins that were linked to 300 deaths globally.

As of today the WHO (world health organization) made an alert on the manufacture of Made-in-India medicines such as cough syrups and vitamins that are linked to 300 deaths globally. These contaminated medical products were previously linked to the deaths of over 88 people in the countries like Uzbekistan and Gambia.


• These cough syrups contained lethal toxins ethylene glycol and diethylene glycol which are used in automobiles such as car brake fluid, aeroplanes, boats and other products not fit for human consumption.


• A few countries including Uzbekistan, Gambia and Nigeria have recently been linked to deaths from the consumption of India-made medicines


• Earlier in October 2022, the World Health Organization (WHO) issued an alert informing that four cough syrups in Gambia, made by India-based Maiden Pharmaceuticals, were of substandard quality. The cough syrups were linked to the death of children in Gambia, many of whom were under the age of 5.
                                                                                                                                                                                                                                        India’s drug controller unit had launched an action on manufacturers like Noida’s Marion biotech, Haryana-based global Pharma and Punjab’s QP Pharmachem.

Few statements
•Union health minister Mansukh Mandviya said that “We have conducted risk-based analysis at more than 125 companies and our squads have visited their facilities. Of these, 71 companies have been served show-cause notices and 18 have been given closure notices.”


• As per the sources, (CDSCO) the central drugs standard control organization, said the health ministry prioritizes making sure that all the medicines are tested for quality control before export and will make sure to take corrective measures.


• Government issued a notice on May 22, the notice stated that Any cough syrup must have a certificate of analysis issued by a government laboratory before it is exported, effective June 1, shared by the health ministry.

Indian pharmaceutical industry is known for its generic medicines and low-cost vaccines globally. Transformed over the years as a vibrant sector, presently Indian Pharma ranks third in pharmaceutical production by volume. The Pharmaceutical industry in India is the third largest in the world in terms of volume and 14th largest in terms of value.


 According to a recent EY FICCI report, as there has been a growing consensus over providing new innovative therapies to patients, the Indian pharmaceutical market is estimated to touch US$ 130 billion in value by the end of 2030. Meanwhile, the global market size of pharmaceutical products is estimated to cross over the US$ 1 trillion mark in 2023

Tags : #coughsyrup #indiancoughsyrup #indianpharma #indianpharmaceutical #pharmaceuticalcompany #gambia #uzbekistan #nigeria #ethyleneglycol #diethyleneglycol #globaldeath #WHO #madeinindia

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026